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Abstract 
 
Lipid droplets are probably the least well characterised cellular organelles. Having long 
been considered simple lipid storage depots, they are now considered to be dynamic 
organelles involved in many biological processes. However, most of the mechanisms 
driving lipid droplets biogenesis, growth and intracellular movement remain largely 
unknown. As for other cellular mechanisms deciphered through the study of viral 
models, hepatitis C virus (HCV) is an original and relevant model for investigations of 
the birth and life of these organelles. Recent studies in this model have raised the 
hypothesis that the HCV core protein induces the redistribution of lipid droplets 
through the regression and regeneration of these organelles in specific intracellular 
domains.  
 
Introduction 
Cytoplasmic lipid droplets (LD) are intracellular structures that store neutral lipids. Until 
recently, they were classified in the same category as glycogen granules, as simple inert 
storage sites for energy, increasing and decreasing as a function of metabolic energy 
requirements. However, considerable interest has recently been focused on LDs as dynamic 
organelles at the hub of lipid exchanges between intracellular compartments and energy 
metabolism (Martin and Parton, 2006; Murphy et al., 2009). Major findings highlighting the 
dynamic nature of LDs include the identification of key proteins involved in LD biology and 
the discovery of differences in the protein and lipid compositions of LDs in different cell 
types and physiological states (Bickel et al., 2009). There is also increasing evidence to 
suggest that LDs interact dynamically with other membrane-bound organelles, including the 
endoplasmic reticulum (ER), mitochondria, endosomes, peroxisomes and the plasma 
membrane, probably as a means of providing these organelles with neutral lipids and 
phospholipids (Goodman 2008 ; Murphy et al., 2009). More intriguingly, LDs have also been 
shown to have a number of unexpected functions such as constituting a protective reservoir 
for unfolded proteins or other compounds unrelated to lipids to prevent harmful interactions 
with other cell components (Ohsaki et al., 2006 ; Welte 2007). 
 However, despite rapid progress in LD research, the mechanisms underlying the 
formation and dynamics of LDs remain elusive. Recent studies on hepatitis C virus (HCV), an 
important human pathogen, have demonstrated that HCV uses LDs as a platform for viral 
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assembly (Miyanari et al., 2007). This phenomenon is linked to the ability of the HCV core 
protein to induce the redistribution of LDs, through the clustering of these organelles in the 
perinuclear area (Boulant et al., 2008 ; Depla et al., 2010). Many other cellular mechanisms 
have already been deciphered by studying viruses, and HCV may be a relevant model for 
elucidating the birth and life of LDs. 
 
LD morphology and composition 
Although best known for their role in lipid storage in mammalian adipocytes in adipose 
tissue, LDs are present in almost all eukaryotic cells, including yeasts, and even in some 
prokaryotes. Unlike vesicular organelles, the aqueous contents of which are enclosed by a 
phospholipid bilayer, LDs consist of a highly hydrophobic lipid core surrounded by a 
phospholipid monolayer (Murphy and Vance 1999; Tauchi-Sato et al., 2002). On 
transmission electron microscopy (TEM) analysis of conventional ultrathin sections, LDs are 
visible as spherical structures with a highly homogeneous content (Fig. 1A). 
 LDs store neutral lipids, predominantly triglycerides and sterol esters. These 
substances are crucial for the cell. Triglycerides are the principle compounds used for energy 
storage, and both triglycerides and sterol esters serve as reservoirs of membrane lipid 
components. Adipocytes contain mostly triglycerides whereas macrophages contain mostly 
sterol esters. Ether-linked glycerolipids also account for 10 to 20% of the lipids in several 
cultured cell lines (Bartz et al., 2007a). The phospholipids forming the monolayer, with their 
inward-pointing acyl chains, are essentially very similar to those found in the ER (Bartz et al., 
2007a). However, different proteins are present on the surface of LDs. Perilipin, which is 
found in adipose tissues, is one of the best studied proteins associated with LDs (Greenberg et 
al., 1991). Perilipin stabilises the LDs and is also essential for lipolysis, becoming highly 
phosphorylated upon adrenergic stimulation, thereby attracting hormone-sensitive lipase to 
the LD (Sztalryd et al., 2003). However, perilipin belongs to a larger family of animal LD-
binding proteins, all containing the PAT domain, named after the three founding members of 
this family: perilipin, adipophilin (or ADRP, for adipose differentiation-related protein) and 
TIP 47 (for tail interacting protein of 47 kDa). More recently, a new nomenclature leading to 
the name of PLIN proteins has been established for the mammalian PAT-proteins (Kimmel et 
al., 2010). Each PAT/PLIN protein has unique tissue and subcellular distributions, and LD-
binding properties consistent with a unique role in LD content management (Goodman 2008). 
Some of these proteins are exchangeable at the surface of LDs in various conditions and 
regulate the storage of lipids within the cell (Wolins et al., 2006; Bickel et al., 2009). 
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Individual cells may also contain subsets of LDs with different populations of PAT/PLIN 
proteins, varying with size, age and the level of metabolic activity (Wolins et al., 2006; 
Brasaemle et al., 2007; Digel et al., 2010).  
 LDs have been subject to many proteomic studies in recent years (Bartz et al., 2007b ; 
Hodges and Wu 2010). These studies unexpectedly picked up proteins regulating trafficking 
pathways, such as members of both the Rab and ADP-ribosylation factor (ARF) families of 
small GTPases, caveolin, and other proteins thought to be specific for vesicle docking events 
in exocytosis pathways. Of the potentially LD-associated Rab proteins, only a limited number 
have been examined in detail in the context of the LD. However, Rab18 has received 
particular attention because it shows specific regulated localisation to the surface of LDs 
(Ozeki et al., 2005, Martin et al., 2005). The identification of these proteins on LDs provides 
evidence for a role for LDs in communications between organelles (Zehmer et al., 2009a). In 
addition, motor proteins, such as dynein and kinesin, have been identified in some LDs, 
suggesting on the possible movement of these structures on microtubules during the transfer 
of molecules to various organelles (Zehmer et al., 2009a). 
 
LD formation 
There is considerable evidence to indicate that LDs are derived from the ER. TEM studies 
have revealed that LDs are tightly associated with the ER membrane (Fig. 1B), and proteomic 
studies of LDs isolated from various cell lines have revealed the presence of many ER 
proteins (Liu et al., 2004; Brasaemle et al., 2004; Wan et al., 2007). It has been suggested that 
LDs associated intimately with the ER, with the ER membrane forming a structure 
resembling an egg cup and holding the LD, which resembles an egg (Robenek et al.,  2006). 
However, the prevailing model for LD formation involves the emergence of LDs from the ER 
lipid bilayer as a lens-shaped mass of neutral lipids that then buds off from the cytoplasmic 
face of the bilayer to form a droplet within the cytoplasm (Brasaemle 2007; Wolins et al., 
2006). It has been suggested that exchangeable PAT/PLIN proteins curve the ER membrane 
to mediate this budding, acting as coatamer-like proteins (Wolins et al., 2006). This model is 
attractive because it accounts for the phospholipid monolayer surrounding LDs and localises 
the birthplace of LDs to the organelle in which the enzymes mediating neutral lipid synthesis 
are found on biochemical analysis. Moreover, the diacylglycerol acyltransferase-2 (DGAT2), 
a key enzyme involved in triglyceride synthesis, is found in areas in which LD are tightly 
associated with the ER, under conditions promoting LD formation (Kuerschner et al., 2008). 
There is some evidence to suggest that LDs never leave the ER, instead constituting 
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specialised regions of the ER. TEM studies have frequently shown continuity between the 
cytosolic leaflet of the ER and the boundary leaflet of the LDs (Blanchette-Mackie et al., 
1995). Moreover, three-dimensional reconstructions of large cellular domains have shown 
that LDs are invariably intimately linked to the ER compartment (Fig. 1B ; see also the 
QuickTime movie of a 3D reconstruction of such large microdomain, provided online as 
supplemental material). This notion that LDs are specialised regions of the ER is attractive 
because this organisation would provide a simple mechanism for the exchange of lipids and 
proteins between these two compartments. For example, during metabolic stress requiring the 
rapid hydrolysis of esterified fatty acids and the release of free fatty acids, the leaflet must 
rapidly shrink. Continuity with the ER would make it possible for this compartment to act as a 
sink for these leaflet components (Goodman 2008). Alternatively, there is evidence to suggest 
that the trafficking of membrane-derived vesicles may connect the ER with LDs that have 
been fully released from the ER membrane (Farese and Walther 2009). However, this model 
cannot account for the fusion of vesicles surrounded by a bilayer membrane with the 
monolayer surrounding LDs. In addition, many of the proteins identified in the LD proteome 
are predicted to have multiple membrane spans and it is difficult to imagine them arranged in 
a single leaflet surrounding a hydrophobic core of neutral lipids (Goodman 2009). These 
observations suggest that these proteins are more likely to be present in specialised ER 
membranes tightly bound to the LD that could be separated from the bulk ER during 
fractionation, thus being purified with the LD. However, this model remains speculative and 
caution should be employed when using it as a basis for other hypotheses. 
 
LD growth and mobilization 
LD size varies tremendously, from a diameter of only 50 to 100 nm to a diameter of 100 µm 
in white adipocytes. LD can also clearly grow in size. It is possible that LDs expand as single 
organelles, like inflated balloons. If LDs remain physically attached to the ER, proteins and 
newly synthesised lipids could diffuse laterally into the LDs. If LDs are fully detached from 
the ER, these proteins and lipids must be transported to the LDs in vesicles, although the 
topological problems arising from the fusion of a vesicular bilayer membrane with the 
monolayer membrane at the surface of LD suggest that this is unlikely. Alternatively, the 
neutral lipids in the LD core may be produced locally by enzymes such as DGAT2, which is 
present on the surface of LDs (Kuerschner et al, 2008). However, any such increase in the 
volume of neutral lipids would need to be matched by a corresponding increase of the 
synthesis of phospholipids at the surface of LD. The recent demonstration that key enzymes 
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required for phospholipid synthesis are present at the LD surface provides support for this 
potential mechanism (Guo et al.,  2008).  
 The fusion of several smaller LDs to form larger LDs may also contribute to LD 
growth (Guo et al., 2008), and models in which SNARE proteins and motor proteins are 
involved in LD fusion have been proposed (Andersson et al, 2006; Boström et al., 2007; 
Olofsson et al., 2008; Ducharme and Bickel 2008). However, due to the extremely low 
frequency of this phenomenon in live imaging, LD fusion remains a controversial subject 
(Thiele and Spandl 2008; Farese and Walther 2009; Cheng et al., 2009; Murphy et al., 2010). 
Indeed, it has been pointed out that LD fusion is not observed in situations in which LD are 
densely packed such that there are obvious signs of mechanical strain, with LDs being pressed 
against each other (Thiele and Spandl 2008). This is remarkable, given that LDs have only a 
monolayer membrane, so their fusion would therefore require only one simple step. It has also 
been argued that the small amount of protein recovered from LD preparations is consistent 
with the absence of a dense coverage of proteins with anti-fusion activities on the surface of 
LDs (Thiele and Spandl 2008). It therefore seems possible that the composition of the LD 
monolayer may contribute to the inhibition of spontaneous fusion. Moreover, LD fusion 
would generate a large excess of phospholipids originating from the surface of the small 
original LDs, and it is unclear how the large LD formed by fusion could simultaneously 
adjust its phospholipid monolayer (Ohsaki et al., 2009).   
 LDs not only grow, they may also shrink through lipolysis induced by the lipases 
present at the LD surface. The proteins of the PAT/PLIN family play a key role in the 
organisation and regulation of this process (Brasaemle 2007). More recently, it has been 
shown that autophagy induced by nutrient deprivation (Singh et al., 2009) or dengue virus 
infection (Heaton and Randall 2010) may also regulate the mobilization of lipids from LDs. 
In adipocytes, it has been suggested that LDs may undergo fission during lipolysis. This 
would greatly increase the surface area of LDs, improving the access of lipases to the neutral-
lipid core (Marcinkiewicz et al., 2006). However, this increase in surface area would require 
more surface phospholipids and the mechanism by which this could be achieved remains 
unclear. It therefore appears most likely that LDs are never completely severed from the ER, 
instead remaining permanently connected to the outer leaflet of the ER membrane. Pioneer 
TEM observations have suggested that LDs accumulate or regress within the confines of ER 
membranes (Blanchette-Mackie et al., 1995). More recent studies have also provided support 
for this model by demonstrating experimentally that LDs are formed from and regress to the 
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ER as part of a cyclic process that does not involve trafficking through the secretory pathway 
(Zehmer et al., 2009b). 
 
Intracellular movements of LD 
Live imaging has shown that LDs move around the cytoplasm in many cells. In some cases, 
the distribution of the entire population of LDs in cells may change dramatically within a few 
hours (Welte 2009). This mobility seems to involve mostly microtubule-based transport. The 
pharmacological disruption of microtubules typically prevents this movement of LDs, 
whereas the disruption of actin filaments has little effect. Moreover, cytoplasmic dynein, a 
minus end-directed microtubule motor, is often physically associated with LDs, and the 
functional inactivation of dynein prevents LDs from moving within the cell in various models 
(Welte 2009). Although it is tempting to speculate that these changes are due to LDs moving 
along the microtubules from one location in the cell to another, as suggested by some movies, 
other interpretations have been considered. It has also been suggested (Welte 2009) that LDs 
may not move as a unit, instead regressing and being regenerated at their destination. The 
requirement of dynein as a co-factor for the formation of a nascent LD is consistent with this 
hypothesis (Andersson et al., 2006). This process would involve lipids from shrinking LDs 
diffusing laterally through the expansive ER network to form new LDs elsewhere in the cell 
(Murphy et al, 2009; Welte 09). 
 
The hepatitis C virus model 
HCV infection is rapidly becoming a major global health issue, with more than 130 million 
people infected worldwide (Alter 2007). Of those exposed to HCV, 80% become chronically 
infected, and at least 30% of carriers go on to develop severe liver diseases such as cirrhosis 
and liver carcinoma. There is currently no vaccine to prevent new infections and the efficacy 
of current therapies remains limited. In recent years, the impact of HCV infection on lipid 
metabolism and in particular the development of a liver steatosis has emerged as a clinically 
important topic in liver diseases (Roingeard and Hourioux 2008; Piver et al., 2010). HCV has 
a positive-sense, single-stranded RNA genome encoding a single polyprotein that is both co- 
and post-translationally cleaved at the ER membrane by host or viral proteases to generate 
several proteins (Moradpour et al., 2007). The N-terminal component of the polyprotein 
encodes the structural proteins: the core protein, which forms the viral capsid, and the two 
envelope proteins that surround the capsid to form the virion. The C-terminal region of the 
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polyprotein contains the non-structural (NS) proteins involved in the formation of replication 
complexes for the synthesis of viral RNA (Moradpour et al., 2007). 
 Many years before a tissue culture system for producing infectious HCV in vitro had 
been developed, the HCV core protein was reported to be associated with the surface of LDs 
(Moradpour et al., 1996 ; Barba et al., 1997). This association is dependent on the release of 
the protein from the polyprotein by two different cellular proteases: signal peptidase (SP) and 
signal peptide peptidase (SPP) (McLauchlan et al., 2002). SP cleaves the polyprotein at the C-
terminus of a signal peptide between the core and envelope proteins, producing an immature 
form of the core protein that is unable to associate with LDs. The second cleavage, by SPP, 
occurs within the signal peptide and generates the mature form of the protein, which is then 
transported toward the LD surface (McLauchlan et al., 2002). During this trafficking step, the 
HCV core protein remains attached to the ER cytosolic monolayer membrane and then to the 
monolayer membrane surrounding the LD, through its C-terminal domain, which probably 
interacts in-plane with these membranes (McLauchlan 2009a). Following the long-awaited 
successful propagation of an HCV strain in cultured hepatic Huh7 cells, it has recently been 
shown that LDs are directly involved in the production of infectious HCV particles (Miyanari 
et al., 2007). This study demonstrated that the HCV core protein on LDs recruits non-
structural proteins and replicated RNA to LD-associated membranes, and that this structural 
arrangement plays a crucial role in the formation of infectious viruses. Disruption of the 
association of HCV core protein with LDs was found to cause a defect in the localisation of 
HCV RNA and non-structural proteins to regions surrounding LDs, thereby preventing 
infectious virus assembly (Miyanari et al., 2007 ; Boulant et al., 2007). Further investigations 
with this infectious HCV system demonstrated that HCV core protein initially attached to a 
discrete site on LDs after processing by SPP, subsequently coating the entire LD (Boulant et 
al., 2007). This observation suggested that there might be a defined loading site for the core 
protein, probably at points of contacts between LDs and the ER membrane (Boulant et al., 
2007). More recently, it has been demonstrated that a key enzyme involved in triglyceride 
synthesis, the diacylglycerol acyltransferase-1 (DGAT1), is involved in the HCV infectious 
cycle. Both DGAT1 and DGAT2 are ER resident enzymes that catalyze the final step in 
triglyceride biosynthesis and are essential in LD biogenesis, but only DGAT2 remains 
associated with the LDs. Recent studies have demonstrated that DGAT1 interacts with the 
HCV core protein and promotes its traffic to the surface of DGAT1-generated LDs (Herker et 
al., 2010). It remains unclear why HCV targets LDs, but this targeting may be linked to the 
contribution of these LDs to the formation of very-low-density lipoproteins (VLDLs) in 
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hepatocytes, as the viruses circulating in chronically infected patients are associated with 
lipoproteins (André et al., 2002; Icard et al.,  2009; McLauchlan 2009b). 
 Nevertheless, one of the key elements underlying the production of infectious virions 
is the modification of LD distribution within cells by HCV core protein, such that LDs tend to 
aggregate in the perinuclear area (Boulant et al., 2008; Roingeard et al., 2008). This 
redistribution of LDs may lead to the close apposition of LDs with sites of viral RNA 
replication containing newly synthesised viral genomes and the non-structural proteins 
(Boulant et al., 2008). HCV RNA is replicated at perinuclear ER-derived membranes known 
as the membranous web (Moradpour et al., 2003), and the clustering of LDs around these 
membranes is thought to increase the likehood of interaction between the HCV core protein 
and the newly synthesised RNA, thereby promoting genome packaging, the first step in virus 
assembly. Light microscopy studies demonstrated that the LD clustering induced by the HCV 
core protein was blocked by disrupting the microtubule network or impairing dynein function 
(Boulant et al., 2008 ; Lyn et al., 2010). The authors naturally interpreted these results as 
indicating a redistribution of the pre-existing LDs through the trafficking of these organelles 
along the microtubule network and toward the centrosome. However, analyses of this 
phenomenon by conventional or three-dimensional TEM have shown that the aggregating 
LDs are much larger that the pre-existing LDs, and do not preferentially cluster in the 
centrosome area (Depla et al., 2010). In addition, aggregated LDs have been shown to emerge 
from ER membranes rich in HCV core protein (Depla et al., 2010; Fig 2). This suggests that 
these aggregated LDs surrounded by the HCV core protein budded from specific ER 
membranes enriched in HCV core protein, consistent with the LD regression/regeneration 
hypothesis outlined above (Fig 3). Indeed, it seems unlikely that LDs dispersed throughout 
the cytoplasm would move specifically towards these areas with a core-rich ER membrane. It 
remains unclear whether the HCV core protein is actively involved in lipid mobilization, 
membrane curvature and LD budding, as suggested for PAT/PLIN proteins (Wolins et al., 
2006; Listenberger et al., 2007) However, the HCV core protein has been shown to displace 
ADRP, like other exchangeable PAT/PLIN proteins (Boulant et al., 2008). Although some 
studies have suggested that the same LD may experience a gradual exchange of PAT/PLIN 
proteins (Wolins et al., 2005), the LD regression/regeneration hypothesis would also provide 
a comprehensive model accounting for the replacement of ADRP by the HCV core protein in 
newly synthesised LDs (Fig 3). Interestingly, LD clustering has also been observed in other 
cellular models, without HCV infection. In some cases, the degree of LD clustering seemed to 
depend on the metabolic state, with lipolysis counteracting clustering (Marcinkiewicz et al., 
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2006). In the yeast model, the absence of seipin, a LD-associated protein, resulted in a LD 
clustering (Szymanski et al., 2007). In contrary, overexpression of various PAT/PLIN 
proteins may also lead to LD clustering (Targett-Adams et al., 2003; Listenberger et al., 
2007). Altogether, these results suggest that the replacement of a given LD-associated protein 
by one or others LD-associated proteins could induce this intracellular relocalisation of LDs. 
This reinforces the hypothesis that, following their biogenesis, LDs remain tethered to the ER 
membrane, allowing the exchange of proteins between the LD surface to occur. 
 
Conclusion and perspectives 
Intracellular LDs have gone from being largely ignored as static cytoplasmic inclusions to 
being actively studied as dynamic organelles regulating not only cellular lipid storage, but 
also lipid exchange with various organelles. However, several fundamental questions about  
the biology of LDs remain unanswered. In particular, we still know little about the process by 
which they are formed. The HCV core protein, which seems able to induce the rapid 
regression and regeneration of cytoplasmic LDs, is a potentially valuable model for the 
visualisation of LD morphogenesis by correlative fluorescence/electron microscopy during 
the first few minutes of LD formation. We need to determine whether the regression and 
regeneration of LDs that seems to be induced by the HCV core protein is a widespread 
mechanism of LD motion also occurring in other contexts. It should be reminded that movies 
provided as supplemental material of several published manuscripts have shown that at least 
some LDs remained intact throughout the period of movement between regions of the cells. 
Future investigation should help to understand the highly regulated, integrated and strongly 
compartmentalised cellular network of metabolism, signalling and trafficking leading to LD 
formation and degradation.  
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Figure 1. Three-dimensional reconstruction from serial ultrathin sections of a 
subcellular domain containing lipid droplets 
(A) Sample of one (central) TEM ultrathin section of this subcellular domain, showing the 
LDs (yellow), ER (light blue), and mitochondria (brown). (B) View of a full reconstruction, 
using the same colour code, of this subcellular domain corresponding to 15 serial TEM 
ultrathin (60-70 nm) sections, showing that all LDs are tightly bound to smooth ER 
membranes. The LDs shown in these TEM photographs are from baby hamster kidney (BHK-
21) cells, and the cellular microdomain was reconstructed with IMOD software, as described 
elsewhere (Roingeard et al., 2008 ; Depla et al., 2010). Scale bar: 1 micrometre. A 
QuickTime movie of this 3D reconstruction is also provided as supplemental material online. 
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Figure 2. HCV core production induces the relocalisation, within a few hours, of lipid 
droplets to perinuclear areas 
(A) On conventional TEM, these clustered LDs are connected to the convoluted electron-
dense ER membrane (arrows). (B) Freeze substitution TEM and immuno-gold labelling with 
a specific monoclonal antibody shows the presence of large amount of HCV core protein in 
these convoluted ER membranes linked to LDs (arrows) and the membranes surrounding 
LDs. The LDs shown on these photomicrographs are from BHK-21 cells (see Depla et al., 
2010 for details of the materials and methods). Scale bars: 1 micrometre (A), 0.5 micrometre 
(B). 
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Figure 3. Possible mechanisms of LD redistribution induced by the HCV core protein 
LDs that have initially emerged from the ER bilayer as a lens-shape mass of neutral lipids 
remain attached to the ER membrane to form a round structure surrounded by a phospholipid 
monolayer containing PAT/PLIN proteins. These LDs dispersed throughout the cell could 
regress towards ER membranes and regenerate in distant specific ER membranes domains 
enriched in HCV core protein. The HCV core protein may contribute to curve the ER 
membrane to mediate the LD budding. The LD regression/regeneration hypothesis provides a 
comprehensive model accounting for the replacement of a host cell PAT/PLIN protein by the 
HCV core protein at the surface of newly synthesised LDs. The structures depicted in this 
model are not drawn to scale. 
 
 
 
